GSK vs ABBV: Which Stock is Better?
Side-by-side comparison of GlaxoSmithKline PLC ADR and AbbVie Inc in 2026
GSK
GlaxoSmithKline PLC ADR
—
ABBV
AbbVie Inc
$256.10
Key Metrics Comparison
| Metric | GSK | ABBV | Winner |
|---|---|---|---|
| Market Cap | $103.31B | $334.34B | ABBV |
| P/E Ratio | 13.49 | 80.54 | GSK |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GSK
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GSK or ABBV a better investment?
Comparing GSK and ABBV: GlaxoSmithKline PLC ADR has a market cap of $103.31B while AbbVie Inc has $334.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GSK and ABBV?
GSK (GlaxoSmithKline PLC ADR) and ABBV (AbbVie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GSK or ABBV?
Based on P/E ratios, GSK trades at a lower multiple (13.5x vs 80.5x).
Which is growing faster: GSK or ABBV?
Both GSK and ABBV show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GSK or ABBV?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GSK or ABBV?
AbbVie Inc (ABBV) is larger with a market cap of $334.34B compared to $103.31B for GSK.
Should I buy GSK or ABBV in 2026?
Both GSK and ABBV have investment merit. GSK trades at $N/A while ABBV trades at $256.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GSK and ABBV stock?
Key differences: Market Cap ($103.31B vs $334.34B), P/E Ratio (13.5x vs 80.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GSK or ABBV in 2026?
The choice between GSK and ABBV depends on your investment goals. ABBV shows higher revenue growth (0.0%). ABBV has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GSK and ABBV?
GSK (GlaxoSmithKline PLC ADR) has a market cap of $103.31B, while ABBV (AbbVie Inc) has a market cap of $334.34B. ABBV is the larger company by market value.